GB0326602D0 - Organic compounds - Google Patents

Organic compounds

Info

Publication number
GB0326602D0
GB0326602D0 GB0326602A GB0326602A GB0326602D0 GB 0326602 D0 GB0326602 D0 GB 0326602D0 GB 0326602 A GB0326602 A GB 0326602A GB 0326602 A GB0326602 A GB 0326602A GB 0326602 D0 GB0326602 D0 GB 0326602D0
Authority
GB
United Kingdom
Prior art keywords
organic compounds
compounds
organic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0326602A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Priority to GB0326602A priority Critical patent/GB0326602D0/en
Publication of GB0326602D0 publication Critical patent/GB0326602D0/en
Priority to MYPI20044662A priority patent/MY158342A/en
Priority to ARP040104157A priority patent/AR047310A1/es
Priority to ES04797866T priority patent/ES2339026T3/es
Priority to EP04797866A priority patent/EP1686964B9/en
Priority to DK04797866.3T priority patent/DK1686964T3/da
Priority to AT04797866T priority patent/ATE455537T1/de
Priority to PCT/EP2004/012870 priority patent/WO2005046645A1/en
Priority to MXPA06005357A priority patent/MXPA06005357A/es
Priority to RU2006120484/15A priority patent/RU2404749C2/ru
Priority to PT04797866T priority patent/PT1686964E/pt
Priority to PE2004001111A priority patent/PE20050581A1/es
Priority to CA2541944A priority patent/CA2541944C/en
Priority to SI200431378T priority patent/SI1686964T1/sl
Priority to JP2006538808A priority patent/JP4682145B2/ja
Priority to TW093134728A priority patent/TWI295178B/zh
Priority to AU2004289055A priority patent/AU2004289055C1/en
Priority to CN200480033487.8A priority patent/CN1878541B/zh
Priority to BRPI0416227A priority patent/BRPI0416227B8/pt
Priority to US10/579,186 priority patent/US7759308B2/en
Priority to NZ546788A priority patent/NZ546788A/en
Priority to KR1020067009270A priority patent/KR101233892B1/ko
Priority to PL04797866T priority patent/PL1686964T3/pl
Priority to DE602004025271T priority patent/DE602004025271D1/de
Priority to ZA200602577A priority patent/ZA200602577B/en
Priority to IL175286A priority patent/IL175286A/en
Priority to MA29019A priority patent/MA28155A1/fr
Priority to EC2006006565A priority patent/ECSP066565A/es
Priority to IS8480A priority patent/IS8480A/is
Priority to NO20062777A priority patent/NO337172B1/no
Priority to HK07100155.4A priority patent/HK1093682A1/xx
Priority to CY20101100222T priority patent/CY1110293T1/el
Priority to HR20100190T priority patent/HRP20100190T1/hr
Priority to US12/796,132 priority patent/US8188037B2/en
Priority to US13/456,681 priority patent/US20120214749A1/en
Priority to CY2015011C priority patent/CY2015011I1/el
Priority to LU92701C priority patent/LU92701I2/xx
Priority to NO2016003C priority patent/NO2016003I2/no
Ceased legal-status Critical Current

Links

GB0326602A 2003-11-14 2003-11-14 Organic compounds Ceased GB0326602D0 (en)

Priority Applications (38)

Application Number Priority Date Filing Date Title
GB0326602A GB0326602D0 (en) 2003-11-14 2003-11-14 Organic compounds
MYPI20044662A MY158342A (en) 2003-11-14 2004-11-09 Pharmaceutical composition
ARP040104157A AR047310A1 (es) 2003-11-14 2004-11-11 Composicion farmaceutica
DE602004025271T DE602004025271D1 (de) 2003-11-14 2004-11-12 Mikroteilchen mit somatostatin-analoga
BRPI0416227A BRPI0416227B8 (pt) 2003-11-14 2004-11-12 micropartículas compreendendo análogos de somatostatina, seu uso, composição famacêutica e kit
NZ546788A NZ546788A (en) 2003-11-14 2004-11-12 Microparticles comprising somatostatin analogues
DK04797866.3T DK1686964T3 (da) 2003-11-14 2004-11-12 Mikropartikler indeholdende somatostatinanaloger
AT04797866T ATE455537T1 (de) 2003-11-14 2004-11-12 Mikroteilchen mit somatostatin-analoga
PCT/EP2004/012870 WO2005046645A1 (en) 2003-11-14 2004-11-12 Microparticles comprising somatostatin analogues
MXPA06005357A MXPA06005357A (es) 2003-11-14 2004-11-12 Microparticulas que comprenden analogos de somatostatina.
RU2006120484/15A RU2404749C2 (ru) 2003-11-14 2004-11-12 Микрочастицы, содержащие аналоги соматостатина
PT04797866T PT1686964E (pt) 2003-11-14 2004-11-12 Micropartículas compreendendo análogos de somatostatina
PE2004001111A PE20050581A1 (es) 2003-11-14 2004-11-12 Microparticulas que comprenden analogos de somatostatina
CA2541944A CA2541944C (en) 2003-11-14 2004-11-12 Microparticles comprising somatostatin analogues
SI200431378T SI1686964T1 (sl) 2003-11-14 2004-11-12 Mikrodelci ki obsegajo somatostatinske analoge
JP2006538808A JP4682145B2 (ja) 2003-11-14 2004-11-12 ソマトスタチンアナログを含む微粒子
TW093134728A TWI295178B (en) 2003-11-14 2004-11-12 Pharmaceutical composition
AU2004289055A AU2004289055C1 (en) 2003-11-14 2004-11-12 Microparticles comprising somatostatin analogues
CN200480033487.8A CN1878541B (zh) 2003-11-14 2004-11-12 包含生长激素释放抑制因子类似物的微粒
ES04797866T ES2339026T3 (es) 2003-11-14 2004-11-12 Microparticulas que comprenden analogos de somatostatina.
US10/579,186 US7759308B2 (en) 2003-11-14 2004-11-12 Microparticles comprising somatostatin analogues
EP04797866A EP1686964B9 (en) 2003-11-14 2004-11-12 Microparticles comprising somatostatin analogues
KR1020067009270A KR101233892B1 (ko) 2003-11-14 2004-11-12 소마토스타틴 유사체를 포함하는 미소입자
PL04797866T PL1686964T3 (pl) 2003-11-14 2004-11-12 Mikrocząstki zawierające analogi somatostatyny
ZA200602577A ZA200602577B (en) 2003-11-14 2006-03-29 Microparticles comprising somatostatin analogues
IL175286A IL175286A (en) 2003-11-14 2006-04-27 Microparticles containing CYCLO [[4– (NH2 – C2H4 – NH – CO – O) PRO} –PHG – DTRP – LYS – TYR (4 – BZL) –PHE] in a free form, salt form or protected form fixed in a polymer matrix, Medicinal preparations containing them and uses in the preparation of medicines
MA29019A MA28155A1 (fr) 2003-11-14 2006-05-11 Composition pharmaceutique
EC2006006565A ECSP066565A (es) 2003-11-14 2006-05-12 Micropartículas que comprenden análogos de somatostatina
IS8480A IS8480A (is) 2003-11-14 2006-05-23 Öragnir sem fela í sér sómatóstatínhliðstæður
NO20062777A NO337172B1 (no) 2003-11-14 2006-06-14 Mikropartikler som innbefatter en somatostatinanalog, farmasøytisk sammensetning, sett og anvendelse derav.
HK07100155.4A HK1093682A1 (en) 2003-11-14 2007-01-04 Microparticles comprising somatostatin analogues
CY20101100222T CY1110293T1 (el) 2003-11-14 2010-03-09 Μικροσωματιδια που περιλαμβανουν αναλογα σωματοστατινης
HR20100190T HRP20100190T1 (hr) 2003-11-14 2010-04-01 Mikročestice koje sadrže analoge somatostatina
US12/796,132 US8188037B2 (en) 2003-11-14 2010-06-08 Microparticles comprising somatostatin analogues
US13/456,681 US20120214749A1 (en) 2003-11-14 2012-04-26 Microparticles comprising somatostatin analogues
CY2015011C CY2015011I1 (el) 2003-11-14 2015-03-26 Μικροσωματιδια που περιλαμβανουν αναλογα σωματοστατινης
LU92701C LU92701I2 (fr) 2003-11-14 2015-04-29 Pasiréotide ou un sel pharmaceutiquement acceptable qui en dérive ou un hydrate qui en dérive
NO2016003C NO2016003I2 (no) 2003-11-14 2016-02-02 Pasireotid eller et farmasøytisk akseptabelt salt derav eller et hvilket som helst hydrat derav

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0326602A GB0326602D0 (en) 2003-11-14 2003-11-14 Organic compounds

Publications (1)

Publication Number Publication Date
GB0326602D0 true GB0326602D0 (en) 2003-12-17

Family

ID=29726577

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0326602A Ceased GB0326602D0 (en) 2003-11-14 2003-11-14 Organic compounds

Country Status (3)

Country Link
CN (1) CN1878541B (zh)
GB (1) GB0326602D0 (zh)
ZA (1) ZA200602577B (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20090387A1 (es) * 2007-05-24 2009-04-28 Novartis Ag Formulacion de pasireotida
US20100151033A1 (en) * 2008-12-15 2010-06-17 Novartis Ag Octreotide depot formulation with constantly high exposure levels
CN105267156B (zh) * 2014-06-23 2018-05-29 深圳翰宇药业股份有限公司 一种帕西瑞肽冻干粉针剂及其制备方法
CN110870853B (zh) * 2018-08-29 2020-12-11 深圳翰宇药业股份有限公司 缓释帕瑞肽微球及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH30995A (en) * 1989-07-07 1997-12-23 Novartis Inc Sustained release formulations of water soluble peptides.
MY147327A (en) * 1995-06-29 2012-11-30 Novartis Ag Somatostatin peptides
AU5678398A (en) * 1997-01-29 1998-08-18 Takeda Chemical Industries Ltd. Sustained-release microspheres, their production and use

Also Published As

Publication number Publication date
ZA200602577B (en) 2007-05-30
CN1878541A (zh) 2006-12-13
CN1878541B (zh) 2013-01-16

Similar Documents

Publication Publication Date Title
IL175435A0 (en) Organic compounds
GB0301259D0 (en) Organic compounds
GB0303503D0 (en) Organic compounds
GB0306715D0 (en) Organic compounds
GB0307856D0 (en) Organic compounds
SI1651034T1 (sl) Organske spojine
GB0302876D0 (en) Organic compounds
GB0307860D0 (en) Organic compounds
GB0300095D0 (en) Organic compounds
GB0326602D0 (en) Organic compounds
GB0301938D0 (en) Organic compounds
GB0301471D0 (en) Organic compounds
GB0302748D0 (en) Organic compounds
GB0303506D0 (en) Organic compounds
GB0302991D0 (en) Organic compounds
GB0306071D0 (en) Organic compounds
GB0307277D0 (en) Organic compounds
GB0307440D0 (en) Organic compounds
GB0306070D0 (en) Organic compounds
GB0301561D0 (en) Organic compounds
GB0307554D0 (en) Organic compounds
GB0301470D0 (en) Organic compounds
GB0305684D0 (en) Organic compounds
GB0305154D0 (en) Organic compounds
GB0304713D0 (en) Organic compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)